Cyclophosphamide
Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS)
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)Small moleculeN/AActive
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 95/ 100
Competitive context
3 Active assets in the Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS) cohort.
Same molecule, other indications
Cyclophosphamide is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →